FDA WARNING_LETTER - Paramount Imports LLC - January 26, 2021
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On September 1, 2020, the FDA issued a Warning Letter to Paramount Imports LLC, identifying them as a domestic importer of cigars subject to user fees under section 919 of the FD&C Act. The letter states that Paramount Imports LLC failed to pay assessed user fees by the last day of the applicable quarter, as required by section 919(b)(6) of the FD&C Act.
This failure to pay user fees renders all regulated tobacco products imported by Paramount Imports LLC adulterated under section 902(4) of the FD&C Act. The introduction or delivery into interstate commerce of adulterated tobacco products is a prohibited act under section 301(a) of the FD&C Act. Furthermore, the FDA will be unable to issue an order finding a new tobacco product described in a pending or future Substantial Equivalence (SE) Report to be substantially equivalent until all assessed fees are paid. Entering a repayment plan does not negate the adulterated status of the products.
Paramount Imports LLC is required to immediately correct these violations and submit a written response within 15 working days. The response must include documentation of user fee payment or contact with OFM to set up a payment plan, and steps taken to prevent future violations, including a timetable for implementation if corrections are ongoing. Failure to comply may result in further FDA action, including civil money penalties, criminal prosecution, seizure, and/or injunction.
ID · 43e9686a-832f-4b70-99ff-0ec7cad3fce5
Full citation text and observation details available on the Dashboard.